“You would think that, whether in psychiatry or general medicine, drugs for almost any other condition would be a better place to start than a drug for schizophrenia," says Dr. Paul Appelbaum.
“I would want a study conducted to see how the technology impacts the doctor-patient relationship,” Dr. Paul Applebaum said. “What kind of message are we communicating?”.
The first set of proposed changes to DSM-5 since the web portal was opened for submissions are now being posted for public comment on the DSM-5 web site, writes Dr. Michael B. First.
Drs. Yuval Neria and Prudence Fisher are examining equine therapy's efficacy. They hope to define a specific standardized equine treatment program for people who have PTSD.
Dr. Jeffrey Lieberman said many psychiatrists would likely want to try digital Abilify, especially for patients who just had their first psychotic episode and are at risk of stopping medication.
Dr. Paul Appelbaum said that many of his colleagues welcome tying mass gun violence to mental issues as a way of getting more resources for underfunded mental health services.
Dr. Jeffrey Lieberman called the result “Very interesting and encouraging.” “It’s the first window into a novel mechanism for antidepressants,” he said.
The first time I saw the movie all put together I cried and I cried. I just felt like ‘look at all these people, look at all they’ve done’,” said Dr. Andrew Solomon.
"The relationship between marijuana and opioid use is complex and that more recent data might have yielded different results in light of changing marijuana use patterns," said Dr. Mark Olfson.
